TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/5/24 19:18 | 1/4/23 | ICVX | Icosavax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | M.d | 249 | 2.34 | 0 | 106 | 90 | 224 | D | ||||||||||||||
1/5/24 19:18 | 1/4/23 | ICVX | Icosavax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | S.d | -1,670 | 15.70 | 0 | -106 | -32 | 224 | D | ||||||||||||||
12/22/23 18:25 | 12/20/23 | ICVX | Icosavax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | S | -184 | 15.46 | 0 | -12 | -5 | 224 | D | ||||||||||||||
8/1/23 20:32 | 7/31/23 | ICVX | Icosavax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | S | -29 | 8.86 | 0 | -3 | -1 | 236 | D | ||||||||||||||
2/15/23 19:58 | 2/13/23 | ICVX | Icosavax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | S | -19 | 10.69 | 0 | -2 | -1 | 239 | D | ||||||||||||||
8/2/22 21:37 | 7/29/22 | ICVX | Icosavax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | S.m | -22 | 6.75 | 0 | -3 | -1 | 239 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |